136
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes

, , , &
Pages 723-728 | Accepted 05 Feb 2004, Published online: 19 Mar 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Bhavik J. Pandya, Morgan Bron, Therese McCall, Andrew P. Yu, Kristina S. Chen, Miles E. Mattson & Eric Q. Wu. (2011) Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus. Current Medical Research and Opinion 27:1, pages 189-195.
Read now
Giuseppe Derosa & Sibilla AT Salvadeo. (2009) Risk management in the treatment of type 2 diabetes with pioglitazone. Diabetes, Metabolic Syndrome and Obesity 2, pages 51-60.
Read now
Erland Erdmann, John Dormandy, Robert Wilcox, Massimo Massi-Benedetti & Bernard Charbonnel. (2007) PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study. Vascular Health and Risk Management 3:4, pages 355-370.
Read now
Jochen Seufert. (2006) A fixed-dose combination of pioglitazone and metformin:a promising alternative in metabolic control. Current Medical Research and Opinion 22:sup2, pages S39-S48.
Read now
Andreas Pfützner, Christian A Schneider & Thomas Forst. (2006) Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effects. Expert Review of Cardiovascular Therapy 4:4, pages 445-459.
Read now
Andreas Pfützner & Thomas Forst. (2006) Pioglitazone: an antidiabetic drug with the potency to reduce cardiovascular mortality. Expert Opinion on Pharmacotherapy 7:4, pages 463-476.
Read now

Articles from other publishers (13)

Edoardo Mannucci, Andrea Giaccari, Marco Gallo, Giovanni Targher, Basilio Pintaudi, Riccardo Candido & Matteo Monami. (2022) Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Nutrition, Metabolism and Cardiovascular Diseases 32:3, pages 529-536.
Crossref
Pooja Singal, Ranganath Muniyappa, Robin Chisholm, Gail Hall, Hui Chen, Michael J. Quon & Kieren J. Mather. (2010) Simple modeling allows prediction of steady-state glucose disposal rate from early data in hyperinsulinemic glucose clamps. American Journal of Physiology-Endocrinology and Metabolism 298:2, pages E229-E236.
Crossref
G. Charpentier & S. Halimi. (2009) Earlier triple therapy with pioglitazone in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 11:9, pages 844-854.
Crossref
Kieren Mather. (2009) Surrogate measures of insulin resistance: of rats, mice, and men. American Journal of Physiology-Endocrinology and Metabolism 296:2, pages E398-E399.
Crossref
Mark Stolar. (2009) Safety and Efficacy of Pioglitazone/Metformin Combination Therapy in Treatment of Type 2 Diabetes: A Rationale for Earlier Use. Clinical Medicine. Therapeutics 1, pages CMT.S2370.
Crossref
P. D. Home & G. Pacini. (2008) Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents. Diabetes, Obesity and Metabolism 10:9, pages 699-718.
Crossref
G. Derosa. (2007) Pioglitazone plus glimepiride: a promising alternative in metabolic control. International Journal of Clinical Practice 61, pages 28-36.
Crossref
M. Hanefeld. (2007) Pioglitazone and sulfonylureas: effectively treating type 2 diabetes. International Journal of Clinical Practice 61, pages 20-27.
Crossref
Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff, Christine Clar & Susanne H Ebrahim. (2006) Pioglitazone for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2010:1.
Crossref
Marília de Brito Gomes. (2006) Glitazonas e síndrome metabólica: mecanismos de ação, fisiopatologia e indicações terapêuticas. Arquivos Brasileiros de Endocrinologia & Metabologia 50:2, pages 271-280.
Crossref
Emma D Deeks & Lesley J Scott. (2006) Pioglitazone/Metformin. Drugs 66:14, pages 1863-1877.
Crossref
M. Roden, M. Laakso, D. Johns, M. Widel, R. Urquhart, C. Richardson, S. Mariz & M. H. Tan. (2005) Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus. Diabetic Medicine 22:8, pages 1101-1106.
Crossref
Laura J. Hampson & Loranne Agius. (2005) Increased Potency and Efficacy of Combined Phosphorylase Inactivation and Glucokinase Activation in Control of Hepatocyte Glycogen Metabolism. Diabetes 54:3, pages 617-623.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.